Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13400994 | 0.97 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL3478277 | 0.95 | TSHR (0.52) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL3478193 | 0.93 | TSHR (0.47) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL13400993 | 0.92 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18503070 | 0.91 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL13400996 | 0.89 | TSHR (0.55) | TSHRTHRBPOLBHTTMAPT | |
| SCHEMBL15706230 | 0.89 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL12205511 | 0.89 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL10535835 | 0.87 | TSHR (0.47) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL20664401 | 0.87 | TSHR (0.57) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3551723-B1 | ADDITIVES FOR LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| US-11441073-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2022-09-13 | — | — | US | disclosed |
| US-11377596-B2 | Liquid-crystalline media | MERCK PATENT GMBH (DE) | 2022-07-05 | — | — | US | disclosed |
| US-11359141-B2 | Additives for liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2022-06-14 | — | — | US | disclosed |
| EP-3331965-B1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2022-01-05 | — | — | EP | disclosed |
| US-11214736-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2022-01-04 | — | — | US | disclosed |
| EP-3257916-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-11-17 | — | — | EP | disclosed |
| US-20210277310-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-09-09 | — | — | US | disclosed |
| EP-3660130-B1 | LIQUID CRYSTAL DISPLAYS AND LIQUID CRYSTALLINE MEDIA WITH HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2021-08-04 | — | — | EP | disclosed |
| US-11072742-B2 | Liquid-crystalline media having homeotropic alignment | MERCK PATENT GMBH (DE) | 2021-07-27 | — | — | US | disclosed |
| WO-2011088882-A1 | POLYMERIZABLE COMPOUNDS AND LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011035842-A1 | POLYMERIZABLE COMPOUNDS AND THEIR USE IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2011-03-31 | — | — | WO | disclosed |
| WO-2010133278-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |
| US-20100272925-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT (DE) | 2010-10-28 | — | — | US | disclosed |
| US-20100272925-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-2243812-A2 | Liquid crystal display | Merck Patent GmbH (DE) | 2010-10-27 | — | — | EP | disclosed |
| US-20100103366-A1 | Cyclohexylene Reactive Mesogens and Their Applications | MERCK PATENT GMBH (DE) | 2010-04-29 | — | — | US | disclosed |
| US-20100103366-A1 | Cyclohexylene Reactive Mesogens and Their Applications | MERCK PATENT GMBH (DE) | 2010-04-29 | — | — | US | disclosed |
| EP-2087067-A1 | CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS | Merck Patent GmbH (DE) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008061606-A1 | CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS | MERCK PATENT GMBH (DE) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272925-A1 | LIQUID-CRYSTAL DISPLAY | KLK3, BPHL, LPXN | TSHR 4669/4885THRB 4756/4885POLB 1907/4885 |
| US-20100103366-A1 | Cyclohexylene Reactive Mesogens and Their Applications | CUTA, MC1R, CTSG | TSHR 3118/4885THRB 4144/4885POLB 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.